Modeling Madness in Mice: One Piece at a Time

Neuron

Volumn 52, Issue 1, 2006, Pages 179-196

  Arguello, P Alexander ^a   Gogos, Joseph A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNESIA; ANHEDONIA; ATTENTION DEFICIT DISORDER; BRAIN DYSFUNCTION; DISEASE MODEL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; MENTAL DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; MICE; MICE, TRANSGENIC; MUTATION;

EID: 33749063363     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2006.09.023     Document Type: Review

References (168)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A., Kandel E.R., and Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88 (1997) 615-626
2. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., van Dyck C.H., Charney D.S., Innis R.B., and Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155 (1998) 761-767
3. Akbarian S., Rios M., Liu R.J., Gold S.J., Fong H.F., Zeiler S., Coppola V., Tessarollo L., Jones K.R., Nestler E.J., et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22 (2002) 4153-4162
4. Aleman A., Hijman R., de Haan E.H., and Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 156 (1999) 1358-1366
5. Anholt R.R., Dilda C.L., Chang S., Fanara J.J., Kulkarni N.H., Ganguly I., Rollmann S.M., Kamdar K.P., and Mackay T.F. The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome. Nat. Genet. 35 (2003) 180-184
6. Arnold J.S., Braunstein E.M., Ohyama T., Groves A.K., Adams J.C., Brown M.C., and Morrow B.E. Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Hum. Mol. Genet. 15 (2006) 1629-1639
7. Babb S.J., and Crystal J.D. Episodic-like memory in the rat. Curr. Biol. 16 (2006) 1317-1321
8. Baddeley A. Working memory. Science 255 (1992) 556-559
9. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273
10. Bender H.U., Almashanu S., Steel G., Hu C.A., Lin W.W., Willis A., Pulver A., and Valle D. Functional consequences of PRODH missense mutations. Am. J. Hum. Genet. 76 (2005) 409-420
11. Birrell J.M., and Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 20 (2000) 4320-4324
12. Brewer W.J., Francey S.M., Wood S.J., Jackson H.J., Pantelis C., Phillips L.J., Yung A.R., Anderson V.A., and McGorry P.D. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am. J. Psychiatry 162 (2005) 71-78
13. Brown V.J., and Bowman E.M. Rodent models of prefrontal cortical function. Trends Neurosci. 25 (2002) 340-343
14. Cabib S., Orsini C., Le Moal M., and Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289 (2000) 463-465
15. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. USA 102 (2005) 8627-8632
16. Cannon T.D., Zorrilla L.E., Shtasel D., Gur R.E., Gur R.C., Marco E.J., Moberg P., and Price R.A. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 51 (1994) 651-661
17. Cannon T.D., Huttunen M.O., Lonnqvist J., Tuulio-Henriksson A., Pirkola T., Glahn D., Finkelstein J., Hietanen M., Kaprio J., and Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am. J. Hum. Genet. 67 (2000) 369-382
18. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62 (2005) 1205-1213
19. Carroll S.B. Genetics and the making of Homo sapiens. Nature 422 (2003) 849-857
20. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57 (2005) 1117-1127
21. Castner S.A., Williams G.V., and Goldman-Rakic P.S. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287 (2000) 2020-2022
22. Chen J., Lipska B.K., and Weinberger D.R. Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol. Psychiatry 59 (2006) 1180-1188
23. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., Henn F.A., Hortnagl H., and Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res. Mol. Brain Res. 121 (2004) 28-36
24. Chudasama Y., and Robbins T.W. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl.) 174 (2004) 86-98
25. Clayton N.S., Bussey T.J., and Dickinson A. Can animals recall the past and plan for the future?. Nat. Rev. Neurosci. 4 (2003) 685-691
26. Colby C.L., and Goldberg M.E. Space and attention in parietal cortex. Annu. Rev. Neurosci. 22 (1999) 319-349
27. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7 (2004) 575-580
28. Costall B., and Naylor R.J. Animal neuropharmacology and its prediction of clinical response. In: Hirsch S.R., and Weinberger D.R. (Eds). Schizophrenia (1995), Blackwell Science Ltd., Oxford 401-424
29. Coyle J.T., and Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl.) 174 (2004) 32-38
30. Crabbe J.C., and Morris R.G. Festina lente: late-night thoughts on high-throughput screening of mouse behavior. Nat. Neurosci. 7 (2004) 1175-1179
31. Crabbe J.C., Wahlsten D., and Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 284 (1999) 1670-1672
32. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., Hitzemann R.J., Maxson S.C., Miner L.L., Silva A.J., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl.) 132 (1997) 107-124
33. Crusio W.E. Flanking gene and genetic background problems in genetically manipulated mice. Biol. Psychiatry 56 (2004) 381-385
34. Cryan J.F., and Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4 (2005) 775-790
35. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148 (1991) 1474-1486
36. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. Suppl. 36 (1992) 61-89
37. Dudchenko P.A. An overview of the tasks used to test working memory in rodents. Neurosci. Biobehav. Rev. 28 (2004) 699-709
38. Dulawa S.C., and Geyer M.A. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39 (2000) 2170-2179
39. Duman R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7 Suppl 1 (2002) S29-S34
40. Duncan G., Miyamoto S., Gu H., Lieberman J., Koller B., and Snouwaert J. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function. Brain Res. 951 (2002) 166-176
41. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
42. Ellenbroek B.A., and Cools A.R. Animal models for the negative symptoms of schizophrenia. Behav. Pharmacol. 11 (2000) 223-233
43. Elvevag B., and Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14 (2000) 1-21
44. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36 (2004) 131-137
45. Escobar M., Oberling P., and Miller R.R. Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neurosci. Biobehav. Rev. 26 (2002) 203-216
46. Feng Y., and Walsh C.A. Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron 44 (2004) 279-293
47. Ferbinteanu J., and Shapiro M.L. Prospective and retrospective memory coding in the hippocampus. Neuron 40 (2003) 1227-1239
48. Floresco S.B., Seamans J.K., and Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J. Neurosci. 17 (1997) 1880-1890
49. Floresco S.B., Geyer M.A., Gold L.H., and Grace A.A. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr. Bull. 31 (2005) 888-894
50. Fortin N.J., Agster K.L., and Eichenbaum H.B. Critical role of the hippocampus in memory for sequences of events. Nat. Neurosci. 5 (2002) 458-462
51. Freimer N., and Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat. Genet. 36 (2004) 1045-1051
52. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
53. Geller B., Badner J.A., Tillman R., Christian S.L., Bolhofner K., and Cook Jr. E.H. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 161 (2004) 1698-1700
54. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., and Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. USA 100 (2003) 8993-8998
55. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?. Trends Neurosci. 19 (1996) 177-181
56. Gerlai R. A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study. Behav. Brain Res. 95 (1998) 91-101
57. Gerlai R., and Clayton N.S. Analysing hippocampal function in transgenic mice: an ethological perspective. Trends Neurosci. 22 (1999) 47-51
58. Geyer M.A. Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?. Dialogues Clin. Neurosci. 8 (2006) 9-16
59. Geyer M.A., and Moghaddam B. Animal models relevant to schizophrenia disorders. In: Davis K.L., Charney D.S., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippincott Williams and Wilkins, Philadelphia 689-701
60. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl.) 156 (2001) 117-154
61. Glickstein S.B., Hof P.R., and Schmauss C. Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J. Neurosci. 22 (2002) 5619-5629
62. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158 (2001) 1367-1377
63. Gogos J.A., and Gerber D.J. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol. Sci. 27 (2006) 226-233
64. Gogos J.A., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., Nadler J.V., and Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21 (1999) 434-439
65. Goldman-Rakic P.S. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 46 (1999) 650-661
66. Gorski J.A., Balogh S.A., Wehner J.M., and Jones K.R. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 121 (2003) 341-354
67. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., Kwon H., Jin S., Jo B., Antonarakis S.E., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat. Neurosci. 8 (2005) 1500-1502
68. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 (2003) 636-645
69. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 (1991) 1-24
70. Gray N.S., and Snowden R.J. The relevance of irrelevance to schizophrenia. Neurosci. Biobehav. Rev. 29 (2005) 989-999
71. Green M.F., and Nuechterlein K.H. Cortical oscillations and schizophrenia: timing is of the essence. Arch. Gen. Psychiatry 56 (1999) 1007-1008
72. Green M.F., and Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 72 (2004) 1-3
73. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 26 (2000) 119-136
74. Green M.F., Olivier B., Crawley J.N., Penn D.L., and Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr. Bull. 31 (2005) 882-887
75. Green E.K., Norton N., Peirce T., Grozeva D., Kirov G., Owen M.J., O'Donovan M.C., and Craddock N. Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation. Mol. Psychiatry 11 (2006) 798-799
76. Grillet N., Pattyn A., Contet C., Kieffer B.L., Goridis C., and Brunet J.F. Generation and characterization of Rgs4 mutant mice. Mol. Cell. Biol. 25 (2005) 4221-4228
77. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl 2 (2003) 17-54
78. Hagan J.J., and Jones D.N. Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr. Bull. 31 (2005) 830-853
79. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 12 (2006) 824-828
80. Hall D., Dhilla A., Charalambous A., Gogos J.A., and Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73 (2003) 370-376
81. Hampton R.R., and Schwartz B.L. Episodic memory in nonhumans: what, and where, is when?. Curr. Opin. Neurobiol. 14 (2004) 192-197
82. Hashimoto R., Straub R.E., Weickert C.S., Hyde T.M., Kleinman J.E., and Weinberger D.R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry 9 (2004) 299-307
83. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12 (2003) 3151-3159
84. Huotari M., Gogos J.A., Karayiorgou M., Koponen O., Forsberg M., Raasmaja A., Hyttinen J., and Mannisto P.T. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur. J. Neurosci. 15 (2002) 246-256
85. Huotari M., Garcia-Horsman J.A., Karayiorgou M., Gogos J.A., and Mannisto P.T. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology (Berl.) 172 (2004) 1-10
86. Jablensky A. The epidemiological horizon. In: Hirsch S.R., and Weinberger D.R. (Eds). Schizophrenia (2003), Blackwell Science Ltd., Oxford 203-231
87. Jacquet H., Demily C., Houy E., Hecketsweiler B., Bou J., Raux G., Lerond J., Allio G., Haouzir S., Tillaux A., et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol. Psychiatry 10 (2005) 479-485
88. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
89. Javitt D.C., Shelley A.M., Silipo G., and Lieberman J.A. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch. Gen. Psychiatry 57 (2000) 1131-1137
90. Jentsch J.D. Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs. Clin. Neurosci. Res. 3 (2003) 303-313
91. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
92. Jentsch J.D., Redmond Jr. D.E., Elsworth J.D., Taylor J.R., Youngren K.D., and Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277 (1997) 953-955
93. Jones M.W., and Wilson M.A. Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task. PLoS Biol. 3 (2005) e402 10.1371/journal.pbio.0030402
94. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7 (2005) 1067-1078
95. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 160 (2003) 13-23
96. Karayiorgou M., and Gogos J.A. The molecular genetics of the 22q11-associated schizophrenia. Brain Res. Mol. Brain Res. 132 (2004) 95-104
97. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., and Lasseter V.K. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 92 (1995) 7612-7616
98. Kellendonk C., Simpson E.H., Polan H.J., Malleret G., Vronskaya S., Winiger V., Moore H., and Kandel E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006) 603-615
99. Kernie S.G., Liebl D.J., and Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19 (2000) 1290-1300
100. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., and Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. USA 103 (2006) 3693-3697
101. Kremen W.S., Seidman L.J., Faraone S.V., Toomey R., and Tsuang M.T. The paradox of normal neuropsychological function in schizophrenia. J. Abnorm. Psychol. 109 (2000) 743-752
102. Kuc K.A., Gregersen B.M., Gannon K.S., and Dodart J.C. Holeboard discrimination learning in mice. Genes Brain Behav. 5 (2006) 355-363
103. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., and Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl. Acad. Sci. USA 103 (2006) 6747-6752
104. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., and Moreau J.L. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav. Pharmacol. 11 (2000) 257-268
105. Li W., Zhang Q., Oiso N., Novak E.K., Gautam R., O'Brien E.P., Tinsley C.L., Blake D.J., Spritz R.A., Copeland N.G., et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet. 35 (2003) 84-89
106. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
107. Liu M., Pereira F.A., Price S.D., Chu M.J., Shope C., Himes D., Eatock R.A., Brownell W.E., Lysakowski A., and Tsai M.J. Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes Dev. 14 (2000) 2839-2854
108. Liu H., Heath S.C., Sobin C., Roos J.L., Galke B.L., Blundell M.L., Lenane M., Robertson B., Wijsman E.M., Rapoport J.L., et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 99 (2002) 3717-3722
109. Logue S.F., Owen E.H., Rasmussen D.L., and Wehner J.M. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 80 (1997) 1075-1086
110. Long J.M., Laporte P., Merscher S., Funke B., Saint-Jore B., Puech A., Kucherlapati R., Morrow B.E., Skoultchi A.I., and Wynshaw-Boris A. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics (2006) 10.1007/s10048-006-0054-0 Published online August 10, 2006
111. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr. Bull. 31 (2005) 139-153
112. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., and Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. USA 96 (1999) 15239-15244
113. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29 (2005) 913-947
114. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., and Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26 (2006) 4752-4762
115. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., and Berman K.F. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch. Gen. Psychiatry 62 (2005) 379-386
116. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., and Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
117. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191
118. Mirnics Z.K., Mirnics K., Terrano D., Lewis D.A., Sisodia S.S., and Schor N.F. DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes. Mol. Psychiatry 8 (2003) 863-878
119. Mirnics K., Korade Z., Arion D., Lazarov O., Unger T., Macioce M., Sabatini M., Terrano D., Douglass K.C., Schor N.F., and Sisodia S.S. Presenilin-1-dependent transcriptome changes. J. Neurosci. 25 (2005) 1571-1578
120. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., Caron M.G., and Tonegawa S. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. USA 100 (2003) 8987-8992
121. Moghaddam B., and Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281 (1998) 1349-1352
122. Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98 (1999) 427-436
123. Monteggia L.M., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., Meuth S., Nagy A., Greene R.W., and Nestler E.J. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. USA 101 (2004) 10827-10832
124. Moore J.H. A global view of epistasis. Nat. Genet. 37 (2005) 13-14
125. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., and Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol. Psychiatry. 60 (2006) 253-264
126. Morris J.A., Kandpal G., Ma L., and Austin C.P. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 12 (2003) 1591-1608
127. Mukai J., Liu H., Burt R.A., Swor D.E., Lai W.S., Karayiorgou M., and Gogos J.A. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36 (2004) 725-731
128. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., et al. Preclinical models: status of basic research in depression. Biol. Psychiatry 52 (2002) 503-528
129. Newton-Cheh C., and Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat. Res. 573 (2005) 54-69
130. O'Tuathaigh C.M., O'Sullivan G.J., Kinsella A., Harvey R.P., Tighe O., Croke D.T., and Waddington J.L. Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 17 (2006) 79-83
131. Owen E.H., Logue S.F., Rasmussen D.L., and Wehner J.M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience 80 (1997) 1087-1099
132. Palmer B.W., Heaton R.K., Paulsen J.S., Kuck J., Braff D., Harris M.J., Zisook S., and Jeste D.V. Is it possible to be schizophrenic yet neuropsychologically normal?. Neuropsychology 11 (1997) 437-446
133. Park S., and Holzman P.S. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry 49 (1992) 975-982
134. Paterlini M., Zakharenko S.S., Lai W.S., Qin J., Zhang H., Mukai J., Westphal K.G., Olivier B., Sulzer D., Pavlidis P., et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8 (2005) 1586-1594
135. Paylor R., and Crawley J.N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl.) 132 (1997) 169-180
136. Paylor R., McIlwain K.L., McAninch R., Nellis A., Yuva-Paylor L.A., Baldini A., and Lindsay E.A. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum. Mol. Genet. 10 (2001) 2645-2650
137. Paylor R., Glaser B., Mupo A., Ataliotis P., Spencer C., Sobotka A., Sparks C., Choi C.H., Oghalai J., Curran S., et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. USA 103 (2006) 7729-7734
138. Petryshen T.L., Middleton F.A., Kirby A., Aldinger K.A., Purcell S., Tahl A.R., Morley C.P., McGann L., Gentile K.L., Rockwell G.N., et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol. Psychiatry 10 (2005) 366-374 328
139. Porteous D.J., and Millar J.K. Disrupted in schizophrenia 1: building brains and memories. Trends Mol. Med. 12 (2006) 255-261
140. Powell C.M., and Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?. Biol. Psychiatry 59 (2006) 1198-1207
141. Pritchard J.K., and Cox N.J. The allelic architecture of human disease genes: common disease-common variant...or not?. Hum. Mol. Genet. 11 (2002) 2417-2423
142. Rebbeck T.R., Spitz M., and Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat. Rev. Genet. 5 (2004) 589-597
143. Renick S.E., Kleven D.T., Chan J., Stenius K., Milner T.A., Pickel V.M., and Fremeau Jr. R.T. The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. J. Neurosci. 19 (1999) 21-33
144. Riccio C.A., Reynolds C.R., Lowe P., and Moore J.J. The continuous performance test: a window on the neural substrates for attention?. Arch. Clin. Neuropsychol. 17 (2002) 235-272
145. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., and Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 16 (2005) 271-275
146. Robbins T.W. Homology in behavioural pharmacology: an approach to animal models of human cognition. Behav. Pharmacol. 9 (1998) 509-519
147. Robbins T.W. Animal models of psychoses. In: Charney D.S., and Nestler E.J. (Eds). Neurobiology of Mental Illness (2004), Oxford University Press, New York 263-286
148. Ross C.A., Margolis R.L., Reading S.A.J., Pletnikov M., and Coyle J.R. Neurobiology of schizophrenia. Neuron 52 (2006) 139-153 this issue
149. Sarter M., and Berntson G.G. Tapping artificially into natural talents. Trends Neurosci. 22 (1999) 300-302
150. Sawa A., and Snyder S.H. Genetics. Two genes link two distinct psychoses. Science 310 (2005) 1128-1129
151. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., and Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 51 (1994) 124-131
152. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., and Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 58 (2005) 446-450
153. Scolnick E.M. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations. Biol. Psychiatry 59 (2006) 1039-1045
154. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003) 297-302
155. Shu T., Ayala R., Nguyen M.D., Xie Z., Gleeson J.G., and Tsai L.H. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44 (2004) 263-277
156. Siapas A.G., Lubenov E.V., and Wilson M.A. Prefrontal phase locking to hippocampal theta oscillations. Neuron 46 (2005) 141-151
157. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7 (2002) 579-593
158. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
159. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
160. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.) 156 (2001) 194-215
161. Talamini L.M., Meeter M., Elvevag B., Murre J.M., and Goldberg T.E. Reduced parahippocampal connectivity produces schizophrenia-like memory deficits in simulated neural circuits with reduced parahippocampal connectivity. Arch. Gen. Psychiatry 62 (2005) 485-493
162. Taylor M.A. Are schizophrenia and affective disorder related? A selective literature review. Am. J. Psychiatry 149 (1992) 22-32
163. Tecott L.H., and Nestler E.J. Neurobehavioral assessment in the information age. Nat. Neurosci. 7 (2004) 462-466
164. Vitelli F., Viola A., Morishima M., Pramparo T., Baldini A., and Lindsay E. TBX1 is required for inner ear morphogenesis. Hum. Mol. Genet. 12 (2003) 2041-2048
165. Waddington J.L., O'Tuathaigh C., O'Sullivan G., Tomiyama K., Koshikawa N., and Croke D.T. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology (Berl) 181 (2005) 611-638
166. Wahlsten D., Metten P., Phillips T.J., Boehm II S.L., Burkhart-Kasch S., Dorow J., Doerksen S., Downing C., Fogarty J., Rodd-Henricks K., et al. Different data from different labs: lessons from studies of gene-environment interaction. J. Neurobiol. 54 (2003) 283-311
167. Weinberger D.R. From neuropathology to neurodevelopment. Lancet 346 (1995) 552-557
168. Yu J., and McMahon A.P. Reproducible and inducible knockdown of gene expression in mice. Genesis 44 (2006) 252-261